Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.1
3.7
Journals
Pathogens
Special Issues
Antimicrobial Resistance of Pathogens Causing Nosocomial Infections
share announcement

Antimicrobial Resistance of Pathogens Causing Nosocomial Infections

A special issue of Pathogens (ISSN 2076-0817).

Deadline for manuscript submissions: 30 September 2024 | Viewed by 1342

Special Issue Editors

Dr. Kidon Sung

E-Mail Website
Guest Editor
Division of Microbiology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, USA
Interests: biofilm; antimicrobial resistance; food safety
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Juhee Ahn

E-Mail Website
Guest Editor
Department of Medical Biomaterials Engineering, Kangwon National University, Chuncheon 24341, Gangwon, Republic of Korea
Interests: microbial pathogenesis; phage control; antibiotic resistance mechanism; food safety
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The emergence of antibiotic resistance is a serious public health problem in pathogens that cause nosocomial infections. Increased antibiotic resistance leads to higher costs of antibiotic use, longer hospital stays higher mortality and higher healthcare costs. The rise in immunodeficient patients, the increased use of indwelling devices, and the use of a wide range of antimicrobial agents in the hospital setting are responsible for increased antimicrobial resistance. ESKAPE is a group of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, which are common causes of life-threatening nosocomial infections among critically ill patients and are potentially antibiotic-resistant. Antibiotic resistance has exploded due to the clonal spread of resistant pathogens in geographically distant regions. Antibiotic resistance rates are particularly high in intensive care units due to antibiotic overuse, incomplete isolation practices, and the prolonged hospitalization of patients who are highly susceptible to hospital-acquired infections. This Special Issue aims to discuss the antimicrobial resistance of pathogens causing nosocomial infections.

Dr. Kidon Sung
Prof. Dr. Juhee Ahn
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial resistance
  • nosocomial infections
  • pathogens
  • hospital-acquired infections
  • ESKAPE

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

18 pages, 355 KiB  
Review
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?
by Gianpiero Tebano, Irene Zaghi, Francesco Baldasso, Chiara Calgarini, Roberta Capozzi, Caterina Salvadori, Monica Cricca and Francesco Cristini
Pathogens 2024, 13(1), 88; https://doi.org/10.3390/pathogens13010088 - 19 Jan 2024
Viewed by 1051
Abstract
Antibiotic resistance in Gram-positive pathogens is a relevant concern, particularly in the hospital setting. Several antibiotics are now available to treat these drug-resistant pathogens, such as daptomycin, dalbavancin, linezolid, tedizolid, ceftaroline, ceftobiprole, and fosfomycin. However, antibiotic resistance can also affect these newer molecules. [...] Read more.
Antibiotic resistance in Gram-positive pathogens is a relevant concern, particularly in the hospital setting. Several antibiotics are now available to treat these drug-resistant pathogens, such as daptomycin, dalbavancin, linezolid, tedizolid, ceftaroline, ceftobiprole, and fosfomycin. However, antibiotic resistance can also affect these newer molecules. Overall, this is not a frequent phenomenon, but it is a growing concern in some settings and can compromise the effectiveness of these molecules, leaving few therapeutic options. We reviewed the available evidence about the epidemiology of antibiotic resistance to these antibiotics and the main molecular mechanisms of resistance, particularly methicillin-resistant Sthaphylococcus aureus, methicillin-resistant coagulase-negative staphylococci, vancomycin-resistant Enterococcus faecium, and penicillin-resistant Streptococcus pneumoniae. We discussed the interpretation of susceptibility tests when minimum inhibitory concentrations are not available. We focused on the risk of the emergence of resistance during treatment, particularly for daptomycin and fosfomycin, and we discussed the strategies that can be implemented to reduce this phenomenon, which can lead to clinical failure despite appropriate antibiotic treatment. The judicious use of antibiotics, epidemiological surveillance, and infection control measures is essential to preserving the efficacy of these drugs. Full article
(This article belongs to the Special Issue Antimicrobial Resistance of Pathogens Causing Nosocomial Infections)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop